Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest announcement is out from TSURUHA Holdings ( (JP:3391) ).
TSURUHA Holdings will record approximately ¥10.6 billion in extraordinary income in the fourth quarter of the fiscal year ending February 28, 2026, stemming from a gain on step acquisition associated with making WELCIA Holdings a consolidated subsidiary following their business integration on December 1, 2025. This one-off gain underscores the financial impact of TSURUHA’s strategic alliance and integration with WELCIA and AEON, which is expected to strengthen its position in Japan’s drugstore market, and the company has already reflected the effects of this transaction in its revised full-year earnings and year-end dividend forecasts for the current fiscal year.
The most recent analyst rating on (JP:3391) stock is a Hold with a Yen2700.00 price target. To see the full list of analyst forecasts on TSURUHA Holdings stock, see the JP:3391 Stock Forecast page.
More about TSURUHA Holdings
TSURUHA Holdings Inc. is a Japan-based operator of drugstore chains, offering pharmaceuticals, daily necessities, cosmetics, and related retail services, primarily through its extensive nationwide store network. The company competes in Japan’s highly consolidated drugstore and pharmacy retail sector, where scale and strategic alliances are key to enhancing purchasing power, logistics efficiency, and market presence.
Average Trading Volume: 2,010,674
Technical Sentiment Signal: Buy
Current Market Cap: Yen1292.8B
For detailed information about 3391 stock, go to TipRanks’ Stock Analysis page.